EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Identification of a Novel KRAS::ETNK1 Fusion Transcript in a Myelodysplastic/Myeloproliferative Overlap Syndrome With Eosinophilia: A Case Report

Marianne Caledec, Hélène Labussière‐Wallet, Juliette Fontaine, Marie Larcher, Fiorenza Barraco, Marie Balsat, Anne‐Marie Daull, Zofia Gross, Juliette Helluin, Sandrine Loron, Lila Gilis, Sophie Ducastelle‐Lepretre, Gaelle Fossard, Mael Heiblig, Pierre Sujobert, Morgane Fontaine, Sandrine Hayette, Vincent Alcazer

eJHaem · 2026-12 · 7 (6)

DOI: 10.1002/jha2.70450 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT This work describes, to our knowledge, the first reported case of a patient with an MDS/MPN overlap syndrome harboring a novel KRAS::ETNK1 fusion transcript. The disease initially presented with eosinophilia, megakaryocyte expansion, mast cell infiltration, and a background of typical MDS/MPN‐associated mutations ( ASXL1 , TET2 , EZH2 , BCOR , and SETBP1 ). Following allogeneic hematopoietic stem cell transplantation, the fusion‐bearing clone disappeared due to a chromosome 12p deletion, and the disease evolved into secondary AML with distinct molecular drivers (MYB, EP300, FAT1, and GATA2). This case provides new insights into rare genetic alterations in MDS/MPN, possible mechanisms of immune‐mediated clonal selection after allogeneic stem cell transplantation, and the dynamics of leukemic evolution. Trial Registration : The authors have confirmed clinical trial registration is not needed for this submission

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →